ERBB2 and breast carcinoma: In another preclinical model of rat neu-overexpressing mouse mammary carcinoma [88,89], it was demonstrated that that loss of HER-2/neu antigen expression was caused via the induction of epigenetic changes in the presence of IFN-γ producing neu-specific T cell responses.